Modafinil for neurobehavioural dysfunction in sleep apnea patients who cannot use standard device-based treatments.

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1004528

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Obstructive sleep apnea (OSA) is often caused by obesity and can result in fall-asleep car crashes. It is often treated by mechanical devices that keep the sleeping airway open. Unfortunately, around half of all patients cannot tolerate these treatments. We propose to help patients reduce obesity with a lifestyle intervention program whilst testing whether their daytime symptoms of sleepiness and poor driving ability can be treated with a wake-promoting drug called modafinil.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $505,830.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Respiratory Diseases

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

accident prevention | obesity | pharmacotherapy | sleep apnoea | sleepiness | weight loss

Related Links